{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-019177","form_type":"8-K","ticker":"DYAI","cik":"0001213809","company_name":"DYADIC INTERNATIONAL INC","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.735133+00:00","generated_at":"2026-05-20T02:27:26.090401+00:00","sec_items":["5.02","5.03","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dyadic appoints Joe Hazelton as President; strategic shift to ancillary proteins with commercial partnerships","bullets":["Hazelton promoted to President, continues as COO; base salary raised 10% to $320,000; 25,000-share option grant with 4-year vesting.","Strategic pivot to ancillary recombinant proteins for life sciences, nutrition, and industrial markets; validated by partnerships with Proliant Health, dairy enzyme firm, and EN3ZYME.","Legacy biopharma programs remain active under CEO Emalfarb; company to pursue corporate rebranding.","CEO states milestones validate strategy; Hazelton to scale commercialization and drive operational execution."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-019177","json":"https://secwatch.observer/filing/0001437749-25-019177.json","markdown":"https://secwatch.observer/filing/0001437749-25-019177.md","text":"https://secwatch.observer/filing/0001437749-25-019177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213809/000143774925019177/0001437749-25-019177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213809/000143774925019177/dyai20250602_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:27:26.090401+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0152ab7037","claim":"Joseph Hazelton was appointed as President at DYADIC INTERNATIONAL INC.","evidence_excerpt":"On May 29, 2025, the board of directors (the \"Board\") of Dyadic International, Inc. (the \"Company\") appointed Joseph Hazelton as President of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213809/000143774925019177/0001437749-25-019177-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"},{"claim_id":"63c622dd97a0c6d1d241b710efabcc1d62b55578","claim":"DYADIC INTERNATIONAL INC: Amended and restated the Third Amended and Restated Bylaws to clarify election inspector roles, virtual meeting procedures, stockholder list provisions, and update officer and board committee meeting provisions (effective 2025-05-29).","evidence_excerpt":"On May 29, 2025, the Board amended and restated the Company’s Third Amended and Restated Bylaws (as amended and restated, the “Bylaws”), effective immediately.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213809/000143774925019177/0001437749-25-019177-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-05-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}